Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Assessing attitudes about genetic testing as a component of continuing medical education.

Mrazek M, Koenig B, Skime M, Snyder K, Hook C, Black J 3rd, Mrazek D.

Acad Psychiatry. 2007 Nov-Dec;31(6):447-51.

PMID:
18079506
2.

Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

de Leon J, Armstrong SC, Cozza KL.

Psychosomatics. 2006 Jan-Feb;47(1):75-85. Review.

PMID:
16384813
3.
4.

Cytochrome P-450 2D6 and 2C19 polymorphisms and length of hospitalization in psychiatry.

Kropp S, Lichtinghagen R, Winterstein K, Schlimme J, Schneider U.

Clin Lab. 2006;52(5-6):237-40.

PMID:
16812949
5.

The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

de Leon J, Susce MT, Murray-Carmichael E.

Mol Diagn Ther. 2006;10(3):135-51. Review.

PMID:
16771600
6.

Utility and adoption of CYP2D6 and CYP2C19 genotyping and its translation into psychiatric clinical practice.

Jürgens G, Jacobsen CB, Rasmussen HB, Werge T, Nordentoft M, Andersen SE.

Acta Psychiatr Scand. 2012 Mar;125(3):228-37. doi: 10.1111/j.1600-0447.2011.01802.x.

PMID:
22128793
7.

Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype.

van der Weide J, van Baalen-Benedek EH, Kootstra-Ros JE.

Ther Drug Monit. 2005 Aug;27(4):478-83.

PMID:
16044105
8.

Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.

Scordo MG, Caputi AP, D'Arrigo C, Fava G, Spina E.

Pharmacol Res. 2004 Aug;50(2):195-200.

PMID:
15177309
9.

Adverse drug reaction monitoring in Jena. Relevance of polymorphic drug metabolizing enzymes for inducing adverse drug reactions.

Hippius M, Buchardt C, Farker K, Kuhn UD, Reimann IR, Hoffmann A.

Exp Toxicol Pathol. 2003 Jun;54(5-6):417-21.

PMID:
12877354
10.

Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy.

Steimer W, Zöpf K, von Amelunxen S, Pfeiffer H, Bachofer J, Popp J, Messner B, Kissling W, Leucht S.

Clin Chem. 2005 Feb;51(2):376-85.

11.

Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).

Matchar DB, Thakur ME, Grossman I, McCrory DC, Orlando LA, Steffens DC, Goldstein DB, Cline KE, Gray RN.

Evid Rep Technol Assess (Full Rep). 2007 Jan;(146):1-77. Review.

12.

[Genotyping of CYP2D6 and CYP2C19].

Slanar O, Drazd'áková M, Babiárová K, Pechandová K, Buzková H, Perlík F, Zima T.

Cas Lek Cesk. 2007;146(9):708-11. Czech.

PMID:
17966194
13.

Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.

Gaikovitch EA, Cascorbi I, Mrozikiewicz PM, Brockmöller J, Frötschl R, Köpke K, Gerloff T, Chernov JN, Roots I.

Eur J Clin Pharmacol. 2003 Aug;59(4):303-12.

PMID:
12879168
14.

Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study.

Egger T, Dormann H, Ahne G, Pahl A, Runge U, Azaz-Livshits T, Neubert A, Criegee-Rieck M, Gassmann KG, Brune K.

Drugs Aging. 2005;22(3):265-72.

PMID:
15813658
15.

Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients.

Dandara C, Masimirembwa CM, Magimba A, Sayi J, Kaaya S, Sommers DK, Snyman JR, Hasler JA.

Eur J Clin Pharmacol. 2001 Apr;57(1):11-7.

PMID:
11372584
16.
17.

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.

Scott SA, Edelmann L, Kornreich R, Erazo M, Desnick RJ.

Pharmacogenomics. 2007 Jul;8(7):721-30. doi: 10.2217/14622416.8.7.721.

PMID:
18240905
18.
19.

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.

Schroth W, Antoniadou L, Fritz P, Schwab M, Muerdter T, Zanger UM, Simon W, Eichelbaum M, Brauch H.

J Clin Oncol. 2007 Nov 20;25(33):5187-93.

PMID:
18024866
20.

Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.

Halling J, Petersen MS, Damkier P, Nielsen F, Grandjean P, Weihe P, Lundgren S, Lundblad MS, Brøsen K.

Eur J Clin Pharmacol. 2005 Aug;61(7):491-7.

PMID:
16025294

Supplemental Content

Support Center